About

ST-segment elevation myocardial infarction (STEMI) remains a leading cause of morbidity and mortality. Challenges in diagnosis remain due to variability in ECG presentation, conditions with similar presentations, variability in the electrical manifestation of ST-segment elevation on ECG, and systems issues with access to rapid diagnosis that can make this diagnosis challenging.

Given the significant morbidity and mortality associated with STEMI, there has been a push to improve the timely diagnosis of STEMI to ensure patients receive therapy faster. However, there remain challenges in diagnosis.

Articles

Ultimaster TANSEI in Complex Coronary Lesions

Published:

31 March 2026

Citation:

Interventional Cardiology 2026;21:e09.

Effectiveness of Hypothermia in PCI for STEMI: A Meta-analysis

Published:

31 March 2026

Citation:

Interventional Cardiology 2026;21:e08.

Zalunfiban before PCI

Published:

24 February 2026

Citation:

European Cardiology Review 2026;21:e08.

Outcomes of Ticagrelor Following Fibrinolysis: Australian Data

Published:

27 January 2026

Citation:

Journal of Asian Pacific Society of Cardiology 2026;5:e03.